Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): A randomised, double-blind, placebo-controlled trial

Lancet

Volumn 357, Issue 9274, 2001, Pages 2085-2089

  Neumann, Franz Josef ^a   Kastrati, Adnan ^b   Miethke, Thomas ^c   Pogatsa Murray, Gisela ^b   Mehilli, Julinda ^b   Valina, Christian ^a   Jogethaei, Nader ^a   Da Costa, Clarissa P ^c   Wagner, Hermann ^c   Schömig, Albert ^a,b  

^a Medizinische Klinik   (Germany)

^b Deutsches Herzzentrum   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; PLACEBO; ROXITHROMYCIN;

ADULT; ARTICLE; CELL PROLIFERATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION;

EID: 0035973296     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)05181-3     Document Type: Article

References (30)

1. Atherosclerosis - An inflammatory disease
2. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
3. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease
4. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
5. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
6. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
7. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
8. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae
9. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity
10. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI- 1 expression: A potential link to accelerated arteriosclerosis
11. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model
12. Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses
13. Pathology of acute and chronic coronary stenting in humans
14. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits
15. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs
16. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty
17. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits
18. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty
19. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study
20. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease
21. Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation
22. The microimmunofluorescence test for Chlamydia pneumoniae infection: Technique and interpretation
23. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions
24. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting
25. Chronic arterial responses to stent implantation: A serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries
26. Time course of restenosis during the first year after emergency coronary stenting
27. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: Serial angiographic and angioscopic follow-up
28. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study
29. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease - Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study